IMMUTEP LTD-SP ADR (IMMP) Fundamental Analysis & Valuation
NASDAQ:IMMP • US45257L1089
Current stock price
0.4623 USD
-0.02 (-3.2%)
At close:
0.4607 USD
0 (-0.35%)
After Hours:
This IMMP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IMMP Profitability Analysis
1.1 Basic Checks
- IMMP had negative earnings in the past year.
- In the past year IMMP has reported a negative cash flow from operations.
- IMMP had negative earnings in each of the past 5 years.
- In the past 5 years IMMP always reported negative operating cash flow.
1.2 Ratios
- IMMP has a Return On Assets (-57.01%) which is in line with its industry peers.
- IMMP's Return On Equity of -84.85% is in line compared to the rest of the industry. IMMP outperforms 47.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -57.01% | ||
| ROE | -84.85% | ||
| ROIC | N/A |
ROA(3y)-29.13%
ROA(5y)-31.07%
ROE(3y)-31.51%
ROE(5y)-33.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for IMMP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. IMMP Health Analysis
2.1 Basic Checks
- IMMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, IMMP has less shares outstanding
- IMMP has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, IMMP has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -4.40, we must say that IMMP is in the distress zone and has some risk of bankruptcy.
- IMMP has a worse Altman-Z score (-4.40) than 61.36% of its industry peers.
- IMMP has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of IMMP (0.01) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.4 |
ROIC/WACCN/A
WACC9.9%
2.3 Liquidity
- A Current Ratio of 2.97 indicates that IMMP has no problem at all paying its short term obligations.
- IMMP has a worse Current ratio (2.97) than 63.50% of its industry peers.
- A Quick Ratio of 2.97 indicates that IMMP has no problem at all paying its short term obligations.
- IMMP has a worse Quick ratio (2.97) than 61.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.97 | ||
| Quick Ratio | 2.97 |
3. IMMP Growth Analysis
3.1 Past
- IMMP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.70%.
- The Revenue has grown by 7581.23% in the past year. This is a very strong growth!
- IMMP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -66.35% yearly.
EPS 1Y (TTM)-69.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)7581.23%
Revenue growth 3Y-38.18%
Revenue growth 5Y-66.35%
Sales Q2Q%6.31%
3.2 Future
- IMMP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.04% yearly.
- IMMP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 130.58% yearly.
EPS Next Y-2.97%
EPS Next 2Y6.21%
EPS Next 3Y-0.66%
EPS Next 5Y28.04%
Revenue Next Year375.9%
Revenue Next 2Y-4.78%
Revenue Next 3Y-0.79%
Revenue Next 5Y130.58%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. IMMP Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for IMMP. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IMMP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.21%
EPS Next 3Y-0.66%
5. IMMP Dividend Analysis
5.1 Amount
- IMMP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IMMP Fundamentals: All Metrics, Ratios and Statistics
0.4623
-0.02 (-3.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)01-29 2026-01-29/bmo
Earnings (Next)07-29 2026-07-29/amc
Inst Owners60.34%
Inst Owner Change-0.12%
Ins Owners2.56%
Ins Owner Change0%
Market Cap68.05M
Revenue(TTM)4.13M
Net Income(TTM)-83.92M
Analysts72.5
Price Target7.4 (1500.69%)
Short Float %0.87%
Short Ratio0.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)107.85%
PT rev (3m)124.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)22.84%
EPS NY rev (3m)25.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)12.91%
Revenue NY rev (3m)38.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 22.99 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.96 | ||
| P/tB | 1.02 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.02
BVpS0.48
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -57.01% | ||
| ROE | -84.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-29.13%
ROA(5y)-31.07%
ROE(3y)-31.51%
ROE(5y)-33.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 3.07% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.97 | ||
| Quick Ratio | 2.97 | ||
| Altman-Z | -4.4 |
F-Score3
WACC9.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-2.97%
EPS Next 2Y6.21%
EPS Next 3Y-0.66%
EPS Next 5Y28.04%
Revenue 1Y (TTM)7581.23%
Revenue growth 3Y-38.18%
Revenue growth 5Y-66.35%
Sales Q2Q%6.31%
Revenue Next Year375.9%
Revenue Next 2Y-4.78%
Revenue Next 3Y-0.79%
Revenue Next 5Y130.58%
EBIT growth 1Y-62.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.86%
EBIT Next 3Y-3.13%
EBIT Next 5Y32.37%
FCF growth 1Y-47.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.67%
OCF growth 3YN/A
OCF growth 5YN/A
IMMUTEP LTD-SP ADR / IMMP Fundamental Analysis FAQ
What is the ChartMill fundamental rating of IMMUTEP LTD-SP ADR (IMMP) stock?
ChartMill assigns a fundamental rating of 2 / 10 to IMMP.
What is the valuation status of IMMUTEP LTD-SP ADR (IMMP) stock?
ChartMill assigns a valuation rating of 0 / 10 to IMMUTEP LTD-SP ADR (IMMP). This can be considered as Overvalued.
Can you provide the profitability details for IMMUTEP LTD-SP ADR?
IMMUTEP LTD-SP ADR (IMMP) has a profitability rating of 1 / 10.